Let’s Stop HIV Together - Part 1: Pharmacology Update: ARVs and Clinical Resources

  • March 25, 2021


Let’s Stop HIV Together - Part 1: Pharmacology Update: ARVs and Clinical Resources 


  • Diane Bruessow, MPAS, PA-C, DFAAPA (LinkedIn)
  • Sam Wijesinghe, DHSc, MS, MPAS, PA-C, AAHIVS (LinkedIn)

Duration: 1 hour

Date: Thursday, March 25, 8:00 pm EDT / 5:00 pm PDT

At the conclusion of this session, participants should be able to:

  1. Utilize the current pharmacology of ARVs in their approach to prescribing 
  2. Reference current guidelines for the use of ARVs as prevention including PrEP and treatment as prevention
  3. Reference HIV Screening, Prevention and Treatment Resources for Clinicians


For providers not routinely treating HIV, it is important to understand HIV screening, prevention, treatment, ARV pharmacology, and effects of stigma among their patients. While ARVs have evolved significantly over the past 4 decades, over 35,000 HIV infections occur annually in the US many of whom are unaware of their HIV status until late-stage diagnosis. The epidemiology continues to change with infections disproportionately affecting southern states, populations of color, and sexual and gender minorities. Guidelines incorporate screening, prevention and treatment for HIV into routine medical care. utilization of antiretroviral mediated prevention including preexposure prophylaxis and treatment as prevention. While HIV treatment options have significantly improved, long term survivors face new complications including certain cancers and inflammatory mediated disease. HIV is considered a chronic disease, yet the societal stigma surrounding this sexually transmitted disease requires that providers approach HIV with a unique perspective.

Register Here: https://lbgtpa.wildapricot.org/event-4205440

APAOG Member Discount Code: ENDHIV21

Powered by Wild Apricot Membership Software